Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
NASDAQ:YTEN
Price:
6.04 USD
2.9%
Market Closed
Updated:
May 11, 2024
Yield10 Bioscience Inc
Net Issuance of Common Stock
|
Yield10 Bioscience Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Net Issuance of Common Stock
$5.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
118%
|
CAGR 10-Years
89%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Issuance of Common Stock
-$1.8B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Issuance of Common Stock
-$768m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Issuance of Common Stock
-$293m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Issuance of Common Stock
-$473.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
5.8m
USD
5.8m
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Issuance of Common Stock amounts to 5.8m USD.
What is Yield10 Bioscience Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
89%
89%
The average annual Net Issuance of Common Stock growth rates for Yield10 Bioscience Inc have been -6% over the past three years , 118% over the past five years , and 89% over the past ten years .
You don't have any saved screeners yet
